PROM1 and neoplasm: As shown in Figure 5A, 5B right, there was no difference of tumor volume observed between the CD133+ and CD133− groups in the first week, however, the growth of tumor in the CD133+ group significantly increased since the 3th week, compared with the CD133− group (P < 0.05).